• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一种保护性炭疽制剂的纯化]

[Purification of a protective anthrax preparation].

作者信息

Vylchev V, Syromashkova M, Mircheva I

出版信息

Zh Mikrobiol Epidemiol Immunobiol. 1976 Apr(3):53-6.

PMID:822659
Abstract

An attempt was made to standardize conditions for obtaining a protective anthrax preparation. A technological scheme permitting to produce 80 mg of a purified lyophilized protective preparation with the activity of 32 immunizing units was applied. It was accepted that 1 IU was the minimal amount of the preparation which provided a survival with the mean time index of 3.0+/-0.5 of guinea pigs after a double immunization at an interval of 14 days. In vitro 1 IU also represented a minimal amount of the preparation which produced three precipitation lines (characteristic of the preparation) in immunoelectrophoretic analysis against the purified anthrax serum. Usually 1 IU in vivo and in vitro corresponded to 2.5 mg of this preparation.

摘要

人们试图规范获取保护性炭疽制剂的条件。采用了一种技术方案,该方案能够生产出80毫克活性为32个免疫单位的纯化冻干保护性制剂。规定1个国际单位(IU)是该制剂的最小量,经14天间隔的两次免疫后,能使豚鼠的平均存活时间指数为3.0±0.5。在体外,1个国际单位也代表该制剂的最小量,在针对纯化炭疽血清的免疫电泳分析中能产生三条沉淀线(该制剂的特征)。通常,体内和体外的1个国际单位相当于2.5毫克这种制剂。

相似文献

1
[Purification of a protective anthrax preparation].[一种保护性炭疽制剂的纯化]
Zh Mikrobiol Epidemiol Immunobiol. 1976 Apr(3):53-6.
2
[Extraction and study of anthrax protective antigen. III. Improvement in the method of obtaining chemical anthrax vaccine under laboratory conditions].[炭疽保护性抗原的提取与研究。III. 实验室条件下化学炭疽疫苗制备方法的改进]
Zh Mikrobiol Epidemiol Immunobiol. 1977 Feb(2):63-7.
3
[Isolation and study of an anthrax protective antigen. V. The dynamics of immunity in vaccination with a concentrated, purified sorbed chemical anthrax vaccine].[炭疽保护性抗原的分离与研究。V. 用浓缩、纯化的吸附化学炭疽疫苗接种时的免疫动态]
Zh Mikrobiol Epidemiol Immunobiol. 1979 May(5):64-7.
4
Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen.用产生保护性抗原的减毒重组炭疽芽孢杆菌菌株进行炭疽疫苗接种。
Infect Immun. 1999 Feb;67(2):562-7. doi: 10.1128/IAI.67.2.562-567.1999.
5
[Standardization of the seeding material in producing live anthrax vaccine].[生产活炭疽疫苗中种子材料的标准化]
Zh Mikrobiol Epidemiol Immunobiol. 1978 Sep(9):42-6.
6
[Immunological properties of the preparations of the anti-anthrax antigen].
Zh Mikrobiol Epidemiol Immunobiol. 1977 Sep(9):41-5.
7
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.用新型纳米乳剂重组炭疽保护性抗原疫苗进行黏膜免疫可抵御炭疽芽孢杆菌孢子攻击。
Infect Immun. 2007 Aug;75(8):4020-9. doi: 10.1128/IAI.00070-07. Epub 2007 May 14.
8
[Role of the components of the S-layer in immunogenicity of Bacillus anthracis].[芽孢衣成分在炭疽芽孢杆菌免疫原性中的作用]
Zh Mikrobiol Epidemiol Immunobiol. 2006 Jan-Feb(1):29-32.
9
[Preparation and study of the anthrax protective antigen. II. Development of test preparations for the assessment of the quality of anthrax chemical vaccines and of the antigens obtained at various stages of its preparation].[炭疽保护性抗原的制备与研究。II. 用于评估炭疽化学疫苗质量以及在其制备各阶段所获抗原质量的试验制剂的研制]
Zh Mikrobiol Epidemiol Immunobiol. 1976 Oct(10):94-8.
10
[Extraction of the exotoxin of anthrax vaccinal strain STI-1].
Zh Mikrobiol Epidemiol Immunobiol. 1974 Feb(2):110-3.